dr. barrientos on the role of acalabrutinib in cll
Published 6 years ago • 439 plays • Length 1:47Download video MP4
Download video MP3
Similar videos
-
2:00
dr. barrientos discusses acalabrutinib in cll
-
1:25
dr. barrientos on the challenges in cll
-
1:39
dr. woyach on the role of acalabrutinib in cll
-
0:43
using acalabrutinib in cll patients with ibrutinib intolerance
-
1:51
dr. barrientos on remaining challenges in cll
-
1:34
dr. barrientos on the impact of combinations in cll
-
0:43
using acalabrutinib in the event of an intolerance to ibrutinib in cll
-
1:20
dr. kay discusses the role of acalabrutinib in cll
-
1:50
dr. barrientos discusses promising agents in cll
-
7:19
acalabrutinib’s role in treating chronic lymphocytic leukemia
-
1:59
dr. barrientos discusses combination strategies in cll
-
1:39
dr. barrientos on the management of elderly patients with cll
-
1:24
dr. barrientos on advances in the treatment landscape for patients with cll
-
1:25
dr. woyach on the role of chemoimmunotherapy in cll
-
0:57
dr. byrd on alacabrutinib's mechanism of action in cll
-
1:03
dr. woyach on the safety of acalabrutinib versus ibrutinib in cll
-
1:15
the current role of acalabrutinib in the treatment of cll
-
0:52
42-month follow-up data of acalabrutinib monotherapy in r/r cll
-
1:47
dr. sharman on the potential approval of acalabrutinib in cll